Sitesinformation.com

Keyword Analysis & Research: tango therapeutics


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
tango therapeutics0.660.8973318
tango0.430.7587095
therapeutics0.980.792615412

Keyword Research: People who searched tango therapeutics also searched

Keyword CPC PCC Volume Score
tango therapeutics0.50.391742
tango therapeutics stock1.570.7988385
tango therapeutics tng3480.040.4771244
tango therapeutics pipeline0.40.75119
tango therapeutics stock price1.020.8300385
tango therapeutics news0.660.9116369
tango therapeutics usp10.640.674339
tango therapeutics gilead1.490.5790795
tango therapeutics careers0.930.7995992
tango therapeutics logo1.281483935
tango therapeutics salaries0.570.4686546
tango therapeutics linkedin0.890.7990732
tango therapeutics glassdoor0.040.2344786
tango therapeutics inc0.080.157380
tango therapeutics sub inc1.440.6939438
tango therapeutics address1.641951471
stoke therapeutics tango0.080.111023
barbara weber tango therapeutics1.570.2275550

Search Results related to tango therapeutics on Search Engine

  • Tango Therapeutics

    tangotx.com

    https://www.tangotx.com/

    WebRobust Pipeline. Bold Leadership. Passionate Team. We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an …

    DA: 72 PA: 51 MOZ Rank: 7 Up or Down: Up

  • Pipeline - Tango Therapeutics

    tangotx.com

    https://www.tangotx.com/pipeline/

    WebWe are leveraging the genetic principle of synthetic lethality and the power of our state-of-the-art CRISPR-based target discovery engine to discover and validate multiple novel …

    DA: 48 PA: 77 MOZ Rank: 13 Up or Down: Up

  • Investor Relations | Tango Therapeutics, Inc

    tangotx.com

    https://ir.tangotx.com/

    WebFeb 7, 2024 · Corporate Profile. Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop …

    DA: 59 PA: 28 MOZ Rank: 54 Up or Down: Up

  • Leadership - Tango Therapeutics

    tangotx.com

    https://www.tangotx.com/leadership/

    WebLeadership. We are leaders in drug discovery, cancer biology, functional genomics and translational medicine pursuing the bold goal of tackling the genetic complexity of cancer. We are focused on drivers of cancer not targeted by current drugs as we seek to address a large unmet need for people with cancer.

    DA: 92 PA: 25 MOZ Rank: 28 Up or Down: Up

  • Approach - Tango Therapeutics

    tangotx.com

    https://www.tangotx.com/science/our-approach/

    WebTango Therapeutics 201 Brookline Ave, Suite 901 Boston, MA 02215 Tel: +1-857-320-4900. Contact; Careers

    DA: 84 PA: 65 MOZ Rank: 4 Up or Down: Up

  • Tango Therapeutics Announces FDA Clearance of Investigational …

    tangotx.com

    https://ir.tangotx.com/news-releases/news-release-details/tango-therapeutics-announces-fda-clearance-investigational-new-1

    WebSep 06, 2023. PDF Version. BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared the …

    DA: 77 PA: 42 MOZ Rank: 79 Up or Down: Up

  • Tango Therapeutics, Inc. (TNGX) - Yahoo Finance

    yahoo.com

    https://finance.yahoo.com/quote/TNGX

    WebTango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein...

    DA: 48 PA: 47 MOZ Rank: 100 Up or Down: Up

  • News Releases | Tango Therapeutics, Inc

    tangotx.com

    https://ir.tangotx.com/news-events/news-releases

    WebJan 03, 2024. Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG348 in Patients with BRCA1/2-Mutant and Other HRD+ Cancers.

    DA: 98 PA: 72 MOZ Rank: 62 Up or Down: Up

  • Tango Therapeutics | LinkedIn

    linkedin.com

    https://www.linkedin.com/company/tango-therapeutics

    WebTango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. Tango was...

    DA: 24 PA: 17 MOZ Rank: 88 Up or Down: Up

  • News Release Details - Tango Therapeutics, Inc

    tangotx.com

    https://ir.tangotx.com/news-releases/news-release-details/tango-therapeutics-announces-fda-clearance-investigational-new

    WebBOSTON, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for …

    DA: 41 PA: 65 MOZ Rank: 68 Up or Down: Up